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The goal of this paper is to construct a new algorithm for the numerical simulations of the evolution of tumour invasion and
metastasis. By means of mathematical model equations and their numerical solutions we investigate how cancer cells can produce
and secrete matrix degradative enzymes, degrade extracellular matrix, and invade due to diﬀusion and haptotactic migration.
For the numerical simulations of the interactions between the tumour cells and the surrounding tissue, we apply numerical
approximations, which are spectrally accurate and based on small amounts of grid-points. Our numerical experiments illustrate
the metastatic ability of tumour cells.
1.Introduction
The analysis of data obtained from the World Health
Organization (WHO) [1] and the UN [2] databases shows
that, at present, cancer is and probably will remain to be
among the leading causes of death worldwide [3–5] being
surpassed only by cardiovascular diseases. According to the
data provided by the WHO, cancer disease is the cause of the
death of roughly six million people yearly [1]. This explains
the major signiﬁcance of the ﬁght against the malignant
conditions, which includes prevention [6], cure [7, 8], and
cancer research.
Tumourdevelopmentisaverycomplexmultistepprocess
involving many intracellular and extracellular phenomena
which are strongly nonlinear and time varying [4, 9–11].
Genomicchangesaswellasmicroenvironmentalfactorssuch
as the extracellular matrix (ECM), various growth factors,
and substrate concentrations have been shown to play a
m a j o rr o l ei nt h ep r o c e s so fc a r c i n o g e n e s i s[ 12].
Generally, tumours can be classiﬁed as benign and
malignant. The growth of benign tumours is self-limiting
and their cells tend to stay in the same place. Malignant
tumours may grow without limitations and their constituent
cells are prone to migrate or metastasize to other parts of the
organism [13–15]. The ability of malignant cancer to invade
the local tissue and to spread throughout the organism is
their most insidious and dangerous property. Metastasis is
the predominant cause of most cancer deaths [14, 16, 17].
The process of metastasis includes angiogenesis and
invasion. Tumour angiogenesis (rapid growth of blood
vessels near the tumour cells) is induced by a secretion of
various growth factors such as vascular endothelial growth
factor (VEGF). These vessels facilitate the inﬂux of oxygen
and other nutrients needed for the development of the
cancer [18]. The process of angiogenesis is followed by
invasion and penetration of cancer cells into surrounding
tissues and possibly by dissemination of cancer cells through
blood vessels. Thus, tumour cells can be carried to a
distant site of the body. There they can implant and initiate
the development of a secondary tumour [14, 16, 19]. An
importantroleintheprocessofcancerinvasionisperformed
by matrix degradative enzymes (MDEs) such as metallo-
proteases (MMPs). They are produced by tumour cells and
digest the ECM, which enables the migration of cancer cells
through the tissue [13, 14, 17].
In the last half century, many mathematical models
describing the process of tumourigenesis have been the
subject of active research. Mathematical and computational
methods have contributed to clarifying the factors that
are suﬃcient to explain experimental and clinical data, to2 Computational and Mathematical Methods in Medicine
deﬁning these factors in precise terms and to suggesting
experiments for calculation of these factors [20]. In addition,
analyses and simulations of mathematical models have been
used for the reduction of the amounts of costly experiments
needed for the development of therapies [21, 22]. It is
strongly believed that mathematical and computational
methods will play a signiﬁcant role in cancer research in
the future. They may improve the understanding of some
complicated features and details of tumour evolution as well
as be eﬀectively used in clinical laboratories, by means of
appropriate model-based decision support systems [4]. We
refer the readers to special issues [23–27] for more complete
bibliography regarding the applications of mathematical and
computational methods to cancer research.
Gatenby and Gawlinski present one of the ﬁrst models of
tumourinvasioninthepapers[28,29].Gatenby[28]consid-
ers the competition between healthy host cells and modiﬁed
(tumour) cells and proposes and analyses several models
formulated in terms of ordinary diﬀerential equations.
Gatenby and Gawlinski [29] present a reaction-diﬀusion
model for the investigation of the role of the alteration of
the microenvironmental acidity induced by cancer cells for
their invasion into the organism. Subsequently, the series
of papers, among others [30–43], have appeared oﬀering
models and detailed analysis of diverse features of cancer
invasion. In this paper, we study the continuum models
of avascular tumour growth investigated by Chaplain et
al. (cf., e.g., [31, 34–37] ) .T h eﬁ r s tm o d e lo ft h i ss e r i e si s
proposed in Anderson et al. [31]. The authors consider three
major variables involved in the process of cancer invasion,
namely, cancer cells, ECM, and MDEs. In order to study
in detail mainly the inﬂuence of the surrounding tissue on
the process of migration of tumour cells, the proliferation
of the latter is not included in the continuum model. The
authors analyse numerically in one and two dimensions the
impact of ECM gradients resulting from the destruction of
ECM by MDE and the role of haptotaxis on cancer invasion.
An extension of this model is presented in Chaplain and
Anderson [34] who consider the role of oxygen as a nutrient
for the tumour cells. The authors propose also a new model
equation for endogenous inhibitors, such as tissue inhibiting
MMPs, that can neutralize MDEs. We include this equation
inourmodel(8),seeSection 2below.ThemodelofChaplain
and Anderson [34] has been further developed by Lolas
[37] and Chaplain and Lolas [35, 36] who have considered
termsdescribingchemotaxis,proliferationofcancercellsand
reestablishment of the ECM. Lolas [37] examines a variety
of continuum models, in particular incorporating the eﬀects
of just chemotaxis, and haptotaxis, and their combination,
and so forth. One of the conclusions of the author is that the
mechanism of chemotaxis without haptotaxis cannot lead
to a successful cancer invasion if there is no proliferation
of tumour cells and reestablishment of ECM. Further novel
ordinary diﬀerential equations that describe the cancer cell
proliferation and the remodeling of the extracellular matrix
re-establishment function allowing the incorporation of the
plasminogen activation cycle are included in the model of
Chaplain and Lolas [36] that also investigates the role of
the uPA system for the cancer invasion. uPA inhibitors
and plasmin have also been investigated in the model by
Chaplain and Lolas [35]. Clear and detailed description of
the biological processes observed during the cancer invasion
and metastasis is provided in [31, 34–37]. In particular, in
these paper, the key stages of the metastatic cascade, the
structureandfunctionsofthemajorconstituentsoftheECM
and the basic representatives of the MDEs participating in
the interactions between the healthy and cancer cells are
systematicallypresentedonthebasisofbroadtheoreticaland
experimental bibliography.
I no u rp a p e r ,w ep r o p o s ead i ﬀerent numerical approach
thantheapproachused,forexample,in[31,34–37].Thegoal
of the paper is to obtain numerical results which are based
on small amounts of spatial grid points applied to the model
equations sothatlow-dimensional vectorsof dataare usedto
make the numerical computations fast. We construct a new
algorithm for the systems [31, 34, 36, 37] by using spectrally
accurate approximations to the terms that model the tumour
cell random motility, the haptotaxis, the MDE diﬀusion,
and the diﬀusion of the endogenous inhibitors. Since the
algorithm computes the solutions with spectral accuracy,
it is based on smaller amounts of spatial grid points than
the amounts of grid points used for the less accurate ﬁnite
diﬀerence approximations (strategy applied, e.g., in [31, 34–
37]),whichconsequentlysavescomputationaltime.Theidea
of using small amounts of spatial grid point and saving time
for computing one solution for one set of parameters, which
has to be repeated many times for many sets, is important,
for example, for the numerical experiments carrying the
goal of estimating parameter values from laboratory data.
This idea is applied in [44] to estimate parameter values
of one of the models presented in [36, 37] from the in
vivo experimental data [45] developed by using transgenic
m o u s em o d e l s .T h en u m e r i c a la p p r o a c hf r o m[ 44]i sb a s e d
on a diﬀerent approximation to the haptotactic term than
the approximations used in this paper and our numerical
schemes are constructed for systems which are various
variants and generalizations of the model investigated in
[44]. Furthermore, because of considering diﬀerent variants
of boundary conditions the schemes in this paper diﬀer from
that of the paper [44].
Additionally to the model presented in [36, 37]a n d
applied in [44], in this paper, we investigate other models,
which are presented in [34] or are combinations of the
model equations from [34, 36, 37]. Moreover, in [44],
the parameter values are evaluated quantitatively from the
laboratory data [45] so that the solutions of the model
equations correlate with the data. Contrarily to [44], in
this paper, we choose the parameter values qualitatively in
order to observe and compare solutions computed with
diﬀerent parameters. This comparison allows to analyse the
inﬂuence of the parameters on the shape of the solutions
and we conclude that complicated interactions between
tumour cells, ECM, MDEs, and endogenous inhibitors can
be directed by choosing the parameter values. Our sequence
of numerical simulations is initiated from the solutions
obtained with the parameter values chosen in [34]( f o r
comparison) and next we gradually change the values and
analyse their inﬂuence on the solutions. Animated graphicalComputational and Mathematical Methods in Medicine 3
visualization of the solutions and how they change according
to the parameters is helpful in observing the inﬂuence of
the parameters on the shape of the solutions. The idea of
using small amounts of spatial grid points and saving time
for computing solutions of the model equations is crucial in
theeﬀectiveutilizationof,forexample,animatedsimulations
of tumours, which can be used as a predictive and visualized
tool in clinical applications. Decreasing the amounts of
spatial grid points used for such visualizations saves not only
the time of demonstrations but also the computer memory.
It is not possible to demonstrate the animated simulations in
papers and we only note that they are interesting and help in
visualization of the complicated biological processes. Instead
oftheanimatedsimulationsweincludesnapshotsatdiﬀerent
stages in time.
The contents of this paper is as follows: the model
equations are described in Section 2, the algorithm is
introducedinSection 3,theresultsofnumericalexperiments
and simulations are presented in Section 4,a n dSection 5
includes our concluding remarks and future research work.
2. Mathematical Model
In this section, we investigate various models of tissue
invasion by cancerous cells. In Section 2.1, we investigate the
Chaplain and Anderson model [34] focusing on interactions
between ECM and cancer tumour and metastatic abilities of
cancer cells. In Section 2.2, we investigate further expansions
of the model and its diﬀerent versions with additional
terms connected with proliferation of tumour cells, ECM
renewal, and diﬀerent functions modelling the production
of MDEs by the tumour cells. Section 2.3 deals with a more
general model with an additional equation, which describes
evolution of endogenous inhibitors.
2.1. Cell-Matrix Interactions and Cell Migration. In the next
section, we construct a numerical scheme for the following
model of tissue invasion:
∂n
∂t
= dn
∂2n
∂x2 −γ
∂
∂x
 
n
∂f
∂x
 
,
∂f
∂t
=− ηmf,
∂m
∂t
= dm
∂2m
∂x2 +αn −βm
(1)
with the space variable x belonging to the scaled domain
[0,1] of tissue, and time t. The model equations (1)d e s c r i b e
interactions between tumour cells, MDEs, and ECM. The
interacting variables are n-tumour cell density, f-ECM
density, and m-MDEs concentration. The system (1)i s
d e r i v e di nd e t a i li n[ 34] and is a part of a more general
system consisting of (1) with an additional fourth equation
for endogenous inhibitor concentration denoted by u.I n
[34], it is assumed that the tumour cells, the MDEs, and
the inhibitors remain within the space domain and zero-
ﬂux boundary conditions are imposed. The fourth equation
for the endogenous inhibitor concentration is dropped
under the additional assumption that negative eﬀect of the
endogenous inhibitors is overcame by the MDEs in an
actively invading tumour. This assumption implies that u =
0 and the general system of four equations is reduced to
(1). In Section 2.3, we investigate the model with all four
equations.
2.2. Migration and Proliferation of Cancer Cells, ECM
Renewal, and MDE Production. We also investigate further
expansions of the model (1), which are introduced, for
example, in [36, 37]. After adding the proliferation term
μ1n(1 − n − f ) to the right-hand side of the equation
governing tumour cell motion (the ﬁrst equation in (1)) and
the ECM renewal term μ2 f(1−n− f) to the right-hand side
of the equation for the ECM (the second equation in (1)), we
obtain the following model:
∂n
∂t
= dn
∂2n
∂x2 −γ
∂
∂x
 
n
∂f
∂x
 
+μ1n
 
1 −n − f
 
,
∂f
∂t
=− ηmf +μ2 f
 
1 −n − f
 
,
∂m
∂t
= dm
∂2m
∂x2 +αn −βm,
(2)
where μ1 is the proliferation rate of the tumour cells and μ2
is the growth rate of the ECM.
We also make experiments with the following modiﬁca-
tion of (2):
∂n
∂t
= dn
∂2n
∂x2 −γ
∂
∂x
 
n
∂f
∂x
 
+μ1n
 
1 −n − f
 
,
∂f
∂t
=− ηmf +μ2 f
 
1 −n − f
 
,
∂m
∂t
= dm
∂2m
∂x2 +αn(1 −n) −βm,
(3)
where the MDE production is modeled by αn(1 − n). The
motivation for choosing such form of the MDE production
in [36, 37] follows from experimental observations of
polarized expression of MDEs at the invading leading edge
of tumour, see, for example, Estreicher et al. [46].
We investigate the model equations (1), (2), and (3)
supplemented by the zero-ﬂux boundary conditions
∂n
∂x
(0,t) =
γ
dn
n(0,t)
∂f
∂x
(0,t),
∂m
∂x
(0,t) = 0 (4)
at x = 0 and either the Dirichlet conditions
n(1,t) = 0, m(1,t) = 0 (5)
or the zero-ﬂux boundary condition
∂n
∂x
(1,t) =
γ
dn
n(1,t)
∂f
∂x
(1,t),
∂m
∂x
(1,t) = 0, (6)
at x = 1. As in [34], we assume that the initial tumour
is centered at x = 0, the initial MDE concentration is4 Computational and Mathematical Methods in Medicine
proportional to the initial tumour cell density with 1/2
as the constant of the proportionality, and the MDE has
already degraded the ECM, thus we consider the same initial
conditions as in [34], which are the following:
n(x,0) = exp
 
−x2
ε
 
,
f(x,0) = 1 −0.5n(x,0),
m(x,0) = 0.5n(x,0),
(7)
for x ∈ [0,1]. The parameter values for the model equations
are speciﬁed in Section 4.
2.3. Production of Endogenous Inhibitors. We additionally
consider the general model
∂n
∂t
= dn
∂2n
∂x2 −γ
∂
∂x
 
n
∂f
∂x
 
+μ1n
 
1 −n − f
 
,
∂f
∂t
=− ηmf +μ2 f
 
1 −n − f
 
,
∂m
∂t
= dm
∂2m
∂x2 +αn − θum−βm,
∂u
∂t
= du
∂2u
∂x2 +F
 
m, f
 
−θum−ρu,
(8)
where the last equation describes evolution of endogenous
inhibitors (concentration of which is denoted by u). This
equationisthefourthequationinthemodel (10.5)proposed
by Chaplain and Anderson in [34], where it is assumed that
endogenous inhibitors are produced by ECM as a response
to the MDEs and the function F(m, f) models the inhibitor
production. The term θum models neutralization of the
MDEsandρumodelsdecayoftheinhibitors.Weassumethat
the initial inhibitor concentration is
u(x,0) = 0 (9)
and impose the zero-ﬂux boundary conditions
∂u
∂x
(0,t) =
∂u
∂x
(1,t) = 0. (10)
O u rg o a li st oc o n s t r u c tan e we ﬃcient algorithm for
solving the models (1), (2), (3), and (8) and investigate the
ability of cancer cells to produce and secrete the MDE, which
then degrade the ECM, and allow the cells to start their
migration towards healthy parts of the tissue.
3. Construction of Numerical Approximations
to TumourCells,ECM,andMDEs
In this section, we construct numerical solutions to the
model equations (1), (2), and (3) supplemented by the initial
conditions (7) and the boundary conditions (4)a n d( 5). For
the numerical solutions, we consider the Chebyshev-Gauss-
Lobatto points
xi =
1
2
−
1
2
cos
iπ
N +1
, (11)
with i = 0,1,...,N + 1, in the scaled domain [0,1] of tissue.
Our goal is to construct approximations to n(xi,t), f (xi,t),
and m(xi,t), for i = 0,1,...,N; the values of the solutions at
xN+1 are known from (5).
Let
n(t) =
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎣
n(x0,t)
n(x1,t)
. . .
n(xN,t)
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎦
,
dn(t)
dt
=
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∂n
∂t
(x0,t)
∂n
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(x1,t)
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(xN,t)
⎤
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,
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∂n
∂x
(x0,t)
∂n
∂x
(x1,t)
. . .
∂n
∂x
(xN,t)
⎤
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, nxx(t) =
⎡
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∂2n
∂x2(x0,t)
∂2n
∂x2(x1,t)
. . .
∂2n
∂x2(xN,t)
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎦
,
(12)
and we use similar notations for f and m. We shall replace
the spatial derivatives in (1) by numerical approximations
constructed for the vectors nxx(t), nx(t), fx(t), fxx(t) in the
ﬁrst equation and for mxx(t) in the third equation. For nx(t),
we apply the following spectrally accurate approximations
∂n
∂x
(xi,t) ≈
N+1  
j=0
di,jn
 
xj,t
 
, (13)
with i = 0,1,...,N +1 ,whe r e
D =
 
di,j
 N+1
i,j=0 (14)
is the ﬁrst-order diﬀerentiation matrix based on the points
(11), see [47, 48]. We also apply the analogous spectrally
accurate approximations
∂f
∂x
(xi,t) ≈
N+1  
j=0
di,j f
 
xj,t
 
,
∂m
∂x
(xi,t) ≈
N+1  
j=0
di,jm
 
xj,t
 
(15)
for fx(t)a n dmx(t), respectively.
Since the exact value of (∂n/∂x)(x0,t)i sg i v e nb y( 4), the
approximation (13) is not needed at the ﬁrst point x0, that
is, for the ﬁrst component of nx(t). Therefore, from (13), the
ﬁrst approximation in (15)w i t hf and i = 0, and from theComputational and Mathematical Methods in Medicine 5
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Figure 1: Tumour cell migration and interactions between the tumour and the surrounding tissue: tumour cell density (solid), ECM density
(dashed), and MDE concentration (dashdot). Solutions to (1), (4), (5), (7) with the parameter values γ = 0.005 and η = 10.
boundary conditions (4)a n d( 5)w eo b t a i n
nx(t) ≈ D
(1)
0 n(t)+
γ
dn
n(x0,t)s
f
0(t)e1, (16)
where
D
(1)
0 =
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢
⎣
00 ··· 0
d1,0 d1,1 ··· d1,N
. . .
. . .
...
. . .
dN,0 dN,1 ··· dN,N
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥
⎦
, e1 =
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢
⎣
1
0
. . .
0
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥
⎦
,
s
f
0(t) =
N+1  
j=0
d0,j f
 
xj,t
 
.
(17)
From (13)a n d( 16) we obtain the following approximation
for the second-order derivatives
nxx(t) ≈ D(1)nx(t)+sn
N+1(t)w
≈ D(1)
 
D
(1)
0 n(t)+
γ
dn
n(x0,t)s
f
0(t)e1
 
+sn
N+1(t)w,
(18)
where
D(1) =
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎣
d0,0 d0,1 ··· d0,N
d1,0 d1,1 ··· d1,N
. . .
. . .
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. . .
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⎤
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, w =
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎣
d0,N+1
d1,N+1
. . .
dN,N+1
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎦
,
sn
N+1(t) =
N+1  
j=0
dN+1,jn
 
xj,t
 
.
(19)
We now construct approximations to fx(t), mx(t), fxx(t),
and mxx(t). From the spectrally accurate approximations
(15)a n df r o m( 4)a n d( 5)w eo b t a i n
fx(t) ≈ D(1) f(t)+ f (xN+1,t)w, (20)
mx(t) ≈ D
(1)
0 m(t). (21)
According to (20), we have the following approximation for
the second-order derivative of f
fxx(t) ≈ D(1)
 
D(1) f(t)+ f (xN+1,t)w
 
+s
f
N+1(t)w, (22)
with the notation
s
f
N+1(t) =
N+1  
j=0
dN+1,j f
 
xj,t
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Figure 2: Evolution in time: the tumour cell density (a), ECM density (b), and MDE concentration (c). Solutions to (1), (4), (5), (7) with
the parameter values as in Figure 1.
From (21)w eh a v e
mxx(t) ≈ D(1)D
(1)
0 m(t)+sm
N+1(t)w, (24)
with the similar notation for m
sm
N+1(t) =
N+1  
j=0
dN+1,jm
 
xj,t
 
. (25)
We now replace the spatial derivatives in the model (1)
by their corresponding approximations. We apply (18), (16),
(20), and (22) to the ﬁrst equation in (1) and obtain its
discrete version written in the following form
dn
dt
(t) = dnD(1)
 
D
(1)
0 n(t)+
γ
dn
n(x0,t)s
f
0(t)e1
 
+dnsn
N+1(t)w
− γ
  
D
(1)
0 n(t)+
γ
dn
n(x0,t)s
f
0(t)e1
 
 
 
D(1) f (t)+ f(xN+1,t)w
 
+n(t)
 
 
D(1)
 
D(1) f(t)+ f(xN+1,t)w
 
+s
f
N+1(t)w
  
,
(26)
where   stands for the component-wise multiplication
between two vectors. The discrete version of the second
equation in (1) is written in the form
df
dt
(t) =− η
 
m(t)   f (t)
 
(27)
and from (24) we obtain the following discrete form of the
third equation in (1)
dm
dt
(t) = dmD(1)D
(1)
0 m(t)+dmsm
N+1(t)w +αn(t) −βm(t).
(28)
The resulting system (26)–(28)i sc o m p o s e do f3 N +3
ordinary diﬀerential equations and is a semidiscrete version
of (1). Note that since the spatial derivatives in (1)a r e
approximated with the spectral accuracy, much smaller
numbers of grid-points xi are needed for (26)–(28) than
for ﬁnite diﬀerence schemes, and time integration of the
smaller systems is more robust and more eﬃcient than time
integration of the ﬁnite diﬀerence systems.
For the models (2)a n d( 3) supplemented with (4)
and the right-hand side boundary condition (6), which is
diﬀerent than (5), we need to apply diﬀerent approximations
than (16), (18), (20), and (22) as they include (5) instead of
(6). For this problem, from (13), instead of (16), we obtain
nx(t) ≈ D
(1)
00 n(t)+
γ
dn
w(0,N+1), (29)
where
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00 ··· 0
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎦
,
w(0,N+1) =
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎣
s
f
0(t)n(x0,t)
0
. . .
0
s
f
N+1(t)n(xN+1,t)
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎦
.
(30)
Further, from (29), we obtain
nxx(t) ≈ D(1)
 
D
(1)
00 n(t)+
γ
dn
w(0,N+1)
 
. (31)Computational and Mathematical Methods in Medicine 7
As in (13)a n d( 15), for the vector
H(t) =
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎣
∂
∂x
 
n(x0,t)
∂f
∂x
(x0,t)
 
∂
∂x
 
n(x1,t)
∂f
∂x
(x1,t)
 
. . .
∂
∂x
 
n(xN,t)
∂f
∂x
(xN,t)
 
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎦
, (32)
of approximations to the haptotactic term we obtain
H(t) ≈ D(1) 
n(t)   fx(t)
 
(33)
and instead of (24), from (6), we obtain
mxx(t) ≈ D
(1)
00 m(t). (34)
From (29), (31), (33), and (34) we obtain the following
scheme for the problem (3), (4), and (6)
dn
dt
(t) = D(1)
 
dnD
(1)
00 n(t)+γw(0,N+1) −γn(t)   fx(t)
 
+μ1n(t)  
 
e −n(t) − f(t)
 
,
df
dt
(t) =− η
 
m(t)   f(t)
 
+μ2 f (t)  
 
e −n(t) − f(t)
 
,
dm
dt
(t) = dmD
(1)
00 m(t)+αn(t)  (e −n(t)) −βm(t),
(35)
where e is a vector entries of which are all 1-s. For (2), the
component αn(t)   (e − n(t) )n e e d st ob er e p l a c e db yαn(t)
in the last equation of (35). From the boundary conditions
(10), we obtain the approximation for the diﬀusion of the
endogenous inhibitors
uxx(t) ≈ D
(1)
00 u(t) (36)
and the semi-discrete version for the last equation in (8)i s
written in the following form
du
dt
(t) = duD
(1)
00 u(t)+ξf(t) −θu(t)  m(t) −ρu(t), (37)
where we assume that the inhibitor production is modelled
by F(m, f) = ξf. The semi-discrete equations have to be
closed by initial conditions chosen according to (7)a n d( 9).
4. Numerical Experiments
We apply the approximations introduced in Section 3 and
begin our series of numerical simulations from (26)–(28),
which correspond to model (1). Results of our numerical
experiments are presented in Figures 1–6. We use the
parameter values dn = 0.001, dm = 0.001, α = 0.1, β = 0,
ε = 0.01, and diﬀerent values of γ and η speciﬁed in the
captions of the ﬁgures.
We apply N = 30, that is 32 grid-points xi, for the
numerical experiments presented in Figures 1–4.T h et i m eo f
integration of the system (26)–(28) based on 32 grid points
is 0.22sec to compute the numerical solutions presented
in Figures 1 and 2 and 0.38sec to compute the numerical
solutions from Figures 3 and 4. For Figures 5 and 6,w ea p p l y
N = 43, that is 45 grid points, and in this case, the time of
integration of (26)–(28)i s0 . 3 5s e c .
Figures 1, 3,a n d5 show snapshots in time and Figures 2,
4,a n d6 show continuous evolution in time of tumour cells,
ECM, and MDE, and their interactions for all x in the space
domain. The numerical results presented in Figures 1 and 2
wereobtainedwithγ = 0.005andη = 10,seealso[34,Figure
10.2]. The results from Figures 3 and 4 were obtained with
γ = 0.01 and η = 10.
Two distinct clusters of tumour cells are seen in Figures 1
and3att = 1andt = 10.Thenumericalresultsshowthatthe
new clusters, which are not seen at t = 0 and appear at t = 1
and t = 10, are created at the leading edge of the tumour as
a result of the diﬀusion and haptotactic migration modeled
by the two components from the right-hand side of the ﬁrst
equationin(1):randommotilitydnΔ2nandhaptotaxis −γΔ·
(nΔf), respectively. Since γ is greater for Figure 3 than for
Figure 1, because of larger haptotactic migration in Figure 3
than in Figure 1, the two clusters seen in Figure 3 are more
separated from each other than the two clusters in Figure 1.
The pictures show the eﬀect of haptotaxis. The small clusters
ofcells,whichbreakawayfromthemainbodyofthetumour,
illustrate the potential for the cancer cells to degrade the
surroundingtissue,migrate,andstartthemetastaticcascade.
The migrations of the small clusters may not be detected
during the processes of medical treatments, and even after
resections of the main tumours, the new small clusters may
initiate recurrences of the disease. A new cluster of tumour
cells broken away from the main body of the tumour is also
observed in Figures 5 and 6, which present numerical data
computed with γ = 0.02 and η = 20.
The next part of our numerical experiments concerns
the models (2)a n d( 3) supplemented by (4), (6), and (7).
The results for model (2) are presented in Figures 7, 8,
11,a n d12 and for model (3) in Figures 9, 10, 13,a n d
14. These experiments start from the initial condition (7)
corresponding to the snapshot in time t = 0i nFigure 1.
We observe that the small clusters of cancer cells separated
from the main tumours are better formed at t = 2 than at
t = 1 and as time evolves the haptotactic migration together
with the production of new cancer cells spread the shapes
of the tumours over the x-domain. We also observe that
the snapshots in time t = 1 in Figures 1, 7,a n d8 look
similar to each other and the models (1), (2), and (3)g i v e
similar results for t ∈ [0,1] although they are supplemented
by the diﬀerent boundary conditions, either (5)o r( 6), and
solved with diﬀerent parameters μ1,μ2 ∈{ 0,0.1,0.5} and
β ∈{ 0,0.07}. However, these similarities are observed only
for t ∈ [0,1] and as time evolves the corresponding solutions
of the models (1), (2), and (3)d i ﬀer from each other. For
example, already at t = 2, Figure 8 shows greater production
of tumour cells than Figure 7.M o r e o v e r ,a tt = 10 and
t = 20, Figure 7 shows weaker MDE production and greater8 Computational and Mathematical Methods in Medicine
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Figure 3: Tumour cell migration and interactions between the tumour and the surrounding tissue: tumour cell density (solid), ECM density
(dashed), and MDE concentration (dashdot). Solutions to (1), (4), (5), (7) with the parameter values γ = 0.01 and η = 10.
0
0.2
0.4
0.6
0.8
1
1.2
1
0.5
0 0
10
20
Time
Space
n
(a)
1
0.5
0
Space
0
0.2
0.4
0.6
0.8
1
1.2
0
10
20
Time
f
(b)
1
0.5
0
Space
0
0.2
0.4
0.6
0.8
1
1.2
0
10
20
Time
m
(c)
Figure 4: Evolution in time: the tumour cell density (a), ECM density (b), and MDE concentration (c). Solutions to (1), (4), (5), (7) with
the parameter values as in Figure 3.
productionofthetumourcellsandtheECMthanin Figure 1
due to the fact that μ1, μ2,a n dβ are greater in Figure 7 than
in Figure 1. On the other hand, also at t = 10 and t =
20, Figure 8 shows greater MDE production than Figure 1.
Although β = 0.07 for Figure 8 and β = 0f o rFigure 1, since
the MDE production is greater in Figure 8 than in Figure 1,
theMDEconcentrationisgreaterinFigure 8thaninFigure 1
and consequently the ECM degradation is more progressive
in Figure 8 than in Figure 1. It can also be observed that
although the parameters dm, α,a n dβ in the third equation
of (1)a n d( 2) are the same for Figures 1, 7,a n d8, the MDE
curves show diﬀerent MDE concentrations in all of these
ﬁgures.
In Figures 7–10,w eo b s e r v ed i ﬀerences due to the
MDE production terms αn and αn(1 − n)i n( 2)a n d( 3),
respectively. The parameter values for Figure 9 are the same
as for Figure 7 and the parameter values for Figure 10 are the
same as for Figure 8 but the MDE production is weaker inComputational and Mathematical Methods in Medicine 9
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Figure 5: Tumour cell migration and interactions between the tumour and the surrounding tissue: tumour cell density (solid), ECM density
(dashed), and MDE concentration (dashdot). Solutions to (1), (4), (5), (7) with the parameter values γ = 0.02 and η = 20.
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Figure 6: Evolution in time: the tumour cell density (a), ECM density (b), and MDE concentration (c). Solutions to (1), (4), (5), (7) with
the parameter values as in Figure 5.
Figure 9 than in Figure 7 and also weaker in Figure 10 than
in Figure 8. The MDE concentrations in Figures 9 and 10
are more uniformly spread out across the x-domain than
in Figures 7 and 8. Furthermore, Figures 9 and 10 illustrate
that the system (3) models a decreasing MDE production
as the tumour invasion progresses and consequently less
MDE concentrations in the regions where the high tumour
cells densities are situated (possibly in these regions the
tumour cells already ﬁnalized their invasion due to lack of
space and move to other regions) than in the regions of
less advanced stage of invasion. This shows that cancer cells
may not need MDEs in the regions where they deal with
lack of space. Similar features are observed in Figures 11–
14, where the clusters separating from the main tumours are
more profound than in Figures 7–10. The same parameter
values were used for Figure 11 as for Figure 13 and the same
parameter values were used for Figure 12 as for Figure 14.
Figures 11 and 12 illustrate numerical solutions to (2),10 Computational and Mathematical Methods in Medicine
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Figure 7: Tumour cell proliferation, migration, ECM re-establishment, and interactions between the tumour and the surrounding tissue:
tumour cell density (solid), ECM density (dashed), and MDE concentration (dashdot). Solutions to (2), (4), (6), (7) with the parameter
values γ = 0.005, η = 10, μ1 = 0.1, μ2 = 0.5, and β = 0.07.
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Figure 8: Tumour cell proliferation, migration, ECM re-establishment, and interactions between the tumour and the surrounding tissue:
tumour cell density (solid), ECM density (dashed), and MDE concentration (dashdot). Solutions to (2), (4), (6), (7) with the parameter
values γ = 0.005, η = 10, μ1 = 0.5, μ2 = 0.1, and β = 0.07.Computational and Mathematical Methods in Medicine 11
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Figure 9: Tumour cell proliferation, migration, ECM re-establishment, and interactions between the tumour and the surrounding tissue:
tumour cell density (solid), ECM density (dashed), and MDE concentration (dashdot). Solutions to (3), (4), (6), (7) with the parameter
values γ = 0.005, η = 10, μ1 = 0.1, μ2 = 0.5, and β = 0.07.
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Figure 10: Tumour cell proliferation, migration, ECM re-establishment, and interactions between the tumour and the surrounding tissue:
tumour cell density (solid), ECM density (dashed), and MDE concentration (dashdot). Solutions to (3), (4), (6), (7) with the parameter
values γ = 0.005, η = 10, μ1 = 0.5, μ2 = 0.1, and β = 0.07.12 Computational and Mathematical Methods in Medicine
0 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
t = 1
(a)
t = 2
0 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
(b)
0 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
t = 10
(c)
0
0.2
0.4
0.6
0.8
1
0 0.2 0.4 0.6 0.8 1
t = 20
(d)
Figure 11: Tumour cell proliferation, migration, ECM re-establishment, and interactions between the tumour and the surrounding tissue:
tumour cell density (solid), ECM density (dashed), and MDE concentration (dashdot). Solutions to (2), (4), (6), (7) with the parameter
values γ = 0.01, η = 10, μ1 = 0.1, μ2 = 0.5, and β = 0.07.
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Figure 12: Tumour cell proliferation, migration, ECM re-establishment, and interactions between the tumour and the surrounding tissue:
tumour cell density (solid), ECM density (dashed), and MDE concentration (dashdot). Solutions to (2), (4), (6), (7) with the parameter
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Figure 13: Tumour cell proliferation, migration, ECM re-establishment, and interactions between the tumour and the surrounding tissue:
tumour cell density (solid), ECM density (dashed), and MDE concentration (dashdot). Solutions to (3), (4), (6), (7) with the parameter
values γ = 0.01, η = 10, μ1 = 0.1, μ2 = 0.5, and β = 0.07.
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Figure 14: Tumour cell proliferation, migration, ECM re-establishment, and interactions between the tumour and the surrounding tissue:
tumour cell density (solid), ECM density (dashed), and MDE concentration (dashdot). Solutions to (3), (4), (6), (7) with the parameter
values γ = 0.01, η = 10, μ1 = 0.5, μ2 = 0.1, and β = 0.07.14 Computational and Mathematical Methods in Medicine
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Figure 15: Tumour cell density (solid), ECM density (dashed), MDE concentration (dashdot), and endogenous inhibitors (dotted).
Solutions to (8)w i t h( 4), (6), (7), (9), (10) and the parameter values γ = 0.005, η = 10, μ1 = 0.5, μ2 = 0.1, β = 0.07, du = dn = dm = 0.001,
θ = 0.05, ξ = 0.03, and ρ = 0.07.
while Figures 13 and 14 illustrate numerical solutions to
(3). Comparison of Figures 11–14 conﬁrms that the term
αn(1 − n)i n( 3) models lower MDE production than the
term αn in (2) (with the same parameter values). We also
observe that since MDE production is lower in Figures 13
and 14 than in Figures 11 and 12, the ECM degradation is
smaller in Figures 13 and 14 t h a ni nF i g u r e s11 and 12.
Figure 15 shows snapshots in time of the four solutions
to the more general model (8) describing the interactions
between the tumour cells, ECM, MDEs, and endogenous
inhibitors. All four proﬁles show that, as time evolves,
the ECM produces endogenous inhibitors, concentration of
which increases in time and their higher concentration is
locatedintheregionswhereECMisnotyetentirelydegraded
rather than in the regions where the degradation is already
eﬀectively developed. The inhibitor proﬁle shows that the
ECM responds to the MDEs by producing the endogenous
inhibitors.
5. Concluding Remarks andFutureDirections
We have constructed a new numerical algorithm for fast
computations of the solutions of the mathematical models
proposed by Chaplain et al. in [34, 36, 37], which consist of
systems of nonlinear partial diﬀerential equations describing
interactions between tumour cells, ECM, and MDEs. The
algorithm is based on spectrally accurate approximations
and small amounts of grid points, which results in ordinary
diﬀerential systems of small dimensions and fast compu-
tations. We have applied the algorithm and presented and
compared the numerical simulations with a variety of model
equations. The simulations demonstrate that the models
describe important features of the interactions between
tumour cells and the surrounding tissue, and in particular
the initiation of a new colony of cells and metastasis.
Our future research work will address the question for
which parameter values and domains the model [34]a n d
the kinetic type model proposed in [49] are equivalent. We
will also address numerical methods with spectrally accurate
approximations for the models with two-dimensional spatial
domain and with diﬀerent kinds of the function F(m, f)
modelling the inhibitor production [34].
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